glp-1 for obesity kenner GLP-1s are not “making people in larger bodies feel like thin people.” That framing oversimplifies human biology and can worsen weight stigma by implying certain bodies deserve less nourishment than others. As Could GLP-1 Drugs Reduce Obesity-Related

By attaching itself to its receptors and activating adenylate cyclase (AC), which raises cAMP levels in the myocardium, glucagon also increases cardiac output

Eating healthy, being active, and managing stress are all part of improving your health and losing weight

When you look at the exhaustive clinical trials conducted for FDA approval, weight loss doesn't appear as a common or even uncommon side effect

95% CI 1.543.89), sulfonylureas (IRR, 1.83

As brand name manufacturing capacity has increased to meet patient demand, the FDA has removed some of the GLP-1 drugs from the drug shortage list, leading to lawsuits filed by the compounding pharmacies against FDA